Haloperidol-Midazolam vs. Haloperidol-Ketamine in Controlling the Agitation of Delirious Patients; a Randomized Clinical Trial.
Archives of Academic Emergency Medicine · 01.01.2023 · 11 (1) · e61-e61
DOI: 10.22037/aaem.v11i1.2095 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Archives of Academic Emergency Medicine, erschienen am 01.01.2023. Verfasst von Mehrad Aghili und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Agitation management in delirious patients is crucial in a crowded emergency department (ED) for both patient and personnel safety. Benzodiazepines, antipsychotics, and newly derived ketamine are among the most commonly used drugs in controlling these cases. This study aimed to compare the effectiveness of haloperidol-midazolam with haloperidol-ketamine combination in this regard.
Methods
In this double-blind randomized clinical trial, delirious patients with agitation in ED were randomly assigned to a group: group A: haloperidol 2.5 mg IV and midazolam 0.05 mg/kg IV or group B: haloperidol 2.5 mg IV and ketamine 0.5 mg/kg IV. Sedative effects as well as side effects at 0, 5, 10, 15, 30 minutes and 1, 2, 4 hours after the intervention were compared between the 2 groups.
Results
We enrolled 140 cases with Altered Mental Status Score (AMSS)≥+2 and mean age of 52.819.4 years (78.5% male). Agitation was significantly controlled in both groups (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Internal Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Aghili, M., AkhavanHejazi, H., Naderpour, Z., Vahidi, E., & Saeedi, M. (2023). Haloperidol-Midazolam vs. Haloperidol-Ketamine in Controlling the Agitation of Delirious Patients; a Randomized Clinical Trial. Archives of Academic Emergency Medicine, 11(1), e61-e61. https://doi.org/10.22037/aaem.v11i1.2095
Vancouver
Aghili M, AkhavanHejazi H, Naderpour Z, Vahidi E, Saeedi M. Haloperidol-Midazolam vs. Haloperidol-Ketamine in Controlling the Agitation of Delirious Patients; a Randomized Clinical Trial. Archives of Academic Emergency Medicine. 2023;11(1):e61-e61. doi:10.22037/aaem.v11i1.2095
BibTeX
@article{Aghili2023,
author = {Aghili, Mehrad and AkhavanHejazi, HamidReza and Naderpour, Zeinab and Vahidi, Elnaz and Saeedi, Morteza},
title = {Haloperidol-Midazolam vs. Haloperidol-Ketamine in Controlling the Agitation of Delirious Patients; a Randomized Clinical Trial},
journal = {Archives of Academic Emergency Medicine},
year = {2023},
volume = {11},
number = {1},
pages = {e61--e61},
doi = {10.22037/aaem.v11i1.2095}
}
EUVIMED